Unknown

Dataset Information

0

Extracellular matrix proteins regulate NK cell function in peripheral tissues.


ABSTRACT: Natural killer (NK) cells reject major histocompatibility complex class I (MHC-I)-deficient bone marrow through direct cytotoxicity but not solid organ transplants devoid of MHC-I. Here, we demonstrate an immediate switch in NK cell function upon exit from the circulation, characterized by a shift from direct cytotoxicity to chemokine/cytokine production. In the skin transplant paradigm, combining an NK cell-specific activating ligand, m157, with missing self MHC-I resulted in complete graft rejection, which was dependent on NK cells as potential helpers and T cells as effectors. Extracellular matrix proteins, collagen I, collagen III, and elastin, blocked NK cell cytotoxicity and promoted their chemokine/cytokine production. NK cell cytotoxicity against MHC-I-deficient melanoma in the skin was markedly increased by blocking tumor collagen deposition. MHC-I down-regulation occurred in solid human cancers but not leukemias, which could be directly targeted by circulating cytotoxic NK cells. Our findings uncover a fundamental mechanism that restricts direct NK cell cytotoxicity in peripheral tissues.

SUBMITTER: Bunting MD 

PROVIDER: S-EPMC8926340 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Extracellular matrix proteins regulate NK cell function in peripheral tissues.

Bunting Mark D MD   Vyas Maulik M   Requesens Marta M   Langenbucher Adam A   Schiferle Erik B EB   Manguso Robert T RT   Lawrence Michael S MS   Demehri Shadmehr S  

Science advances 20220316 11


Natural killer (NK) cells reject major histocompatibility complex class I (MHC-I)-deficient bone marrow through direct cytotoxicity but not solid organ transplants devoid of MHC-I. Here, we demonstrate an immediate switch in NK cell function upon exit from the circulation, characterized by a shift from direct cytotoxicity to chemokine/cytokine production. In the skin transplant paradigm, combining an NK cell-specific activating ligand, m157, with missing self MHC-I resulted in complete graft rej  ...[more]

Similar Datasets

| S-EPMC7000552 | biostudies-literature
| S-EPMC7696558 | biostudies-literature
| S-EPMC5253110 | biostudies-literature
| S-EPMC3762919 | biostudies-literature
| S-EPMC3947227 | biostudies-literature
| S-EPMC8318011 | biostudies-literature
| S-EPMC5503247 | biostudies-literature
| S-EPMC3766584 | biostudies-literature
| S-EPMC4362242 | biostudies-literature
| S-EPMC6637938 | biostudies-literature